Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro

被引:59
作者
Gaillard, PJ [1 ]
de Boer, AG [1 ]
Breimer, DD [1 ]
机构
[1] Leiden Univ, Gorlaeus Labs, Dept Pharmacol, LACDR,Blood Brain Barrier Res Grp, NL-2300 RA Leiden, Netherlands
关键词
blood-brain barrier; lipopolysaccharide; inflammation; brain capillary endothelial cells; brain astrocytes;
D O I
10.1016/S0026-2862(02)00009-2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Lipopolysaccharide-induced changes in blood-brain barrier (BBB) permeability were investigated with a pharmacological approach in vitro. Lipopolysaccharide induced a concentration- and time-dependent (non)reversible opening of the BBB, and brain astrocytes make brain capillary endothelial cells (BCEC) resistant to this BBB disruption. De novo protein synthesis was essential for the recovery, because cycloheximide prevented the recovery process. Dexamethasone pretreated BCEC were more resistant to lipopolysaccharide, while no protective response was induced by heat shock nor by inhibition of P-glycoprotein. BBB opening was tempered by free radical inhibitors (i.e., pretreatment with N-acetyl-cysteine or uric acid combined with deferroxamine mesylate). No effects of modulators of prostanoid-, leukotriene-, or platelet-activating factor pathways were observed. Therefore, lipopolysaccharide-induced BBB opening seems to be primarily mediated by excessive free radical production. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 23 条
[1]   Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the p-glycoprotein blocker PSC833 [J].
Bezombes, C ;
Maestre, N ;
Laurent, G ;
Levade, T ;
Bettaïeb, A ;
Jaffrézou, JP .
FASEB JOURNAL, 1998, 12 (01) :101-109
[2]   ENZYMATIC BARRIER PROTECTS BRAIN CAPILLARIES FROM LEUKOTRIENE C-4 [J].
BLACK, KL ;
BABA, T ;
PARDRIDGE, WM .
JOURNAL OF NEUROSURGERY, 1994, 81 (05) :745-751
[3]  
CAMUSSI G, 1995, J IMMUNOL, V155, P316
[4]  
CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974
[5]   Reactive oxygen species and antioxidants in inflammatory diseases [J].
Chapple, ILC .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1997, 24 (05) :287-296
[6]   Glucocorticoid-mediated repression of nuclear factor-kappa B-dependent transcription involves direct interference with transactivation [J].
DeBosscher, K ;
Schmitz, ML ;
Vanden Berghe, W ;
Plaisance, S ;
Fiers, W ;
Haegeman, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13504-13509
[7]   Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration [J].
deVries, HE ;
Eppens, EF ;
Prins, M ;
Kuiper, J ;
vanBerkel, TJC ;
deBoer, AG ;
Breimer, DD .
PHARMACEUTICAL RESEARCH, 1995, 12 (12) :1932-1936
[8]  
DeVries HE, 1996, J PHARMACOL EXP THER, V277, P1418
[9]   Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NF kappa B activation [J].
Feinstein, DL ;
Galea, E ;
Aquino, DA ;
Li, GC ;
Xu, H ;
Reis, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17724-17732
[10]   Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes [J].
Gaillard, PJ ;
Voorwinden, LH ;
Nielsen, JL ;
Ivanov, A ;
Atsumi, R ;
Engman, H ;
Ringbom, C ;
de Boer, AG ;
Breimer, DD .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (03) :215-222